Indian Academy of Paediatrics underlines need for paediatric pneumococcal surveillance

Advertisement
The counterpart of Indian Academy of Paediatrics (IAP) in Pune has reinstated the need for paediatric pneumococcal surveillance-in order to reduce the burden of severe pneumonia in terms of morbidity and mortality for children under the age of 5 years. Statically, this figure remains untraced, more specifically at the state level.
Designed to appropriately measure these untapped numbers, and also effectively monitor the situation, IAP, the largest association which represents paediatricians or child specialists interests has taken the initiative to formulate this surveillance.
Different measures are being taken into consideration to arrive at a decision to monitor the situation , including factors like the increasing antibiotic resistance, inadequate vaccine coverage as critical areas. Immunization is considered to be the most safe and cost-effective measure to prevent pneumonia and reduce child mortality.
As per the recommendation guidelines of the WHO, pneumococcal conjugate vaccine (PCV) in childhood immunization programmes worldwide, can be very effective in case the mortality rate is more than 50 per 1,000 live birth-under the age of five.
Designed to appropriately measure these untapped numbers, and also effectively monitor the situation, IAP, the largest association which represents paediatricians or child specialists interests has taken the initiative to formulate this surveillance.
Different measures are being taken into consideration to arrive at a decision to monitor the situation , including factors like the increasing antibiotic resistance, inadequate vaccine coverage as critical areas. Immunization is considered to be the most safe and cost-effective measure to prevent pneumonia and reduce child mortality.
As per the recommendation guidelines of the WHO, pneumococcal conjugate vaccine (PCV) in childhood immunization programmes worldwide, can be very effective in case the mortality rate is more than 50 per 1,000 live birth-under the age of five.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.